Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FareWell
San Francisco, California, United Statesfarewellmilwaukee.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
As of August 2017, FareWell was developing and launching a digital therapeutic platform aimed at treating and reversing type II diabetes and heart disease in workplace populations. The company positioned its solution as a first-line treatment to displace medications by leveraging lifestyle medicine, nutrition science, behavioral change techniques, health coaching, and culinary education. Clinical results were not detailed in public sources.
No recent clinical trial data or commercial updates are available after this period.
The leadership team included CEO/co-founder Kevin Appelbaum and Chief Science Officer Dr. David Katz.
The company's approach focused on using digital tools to deliver evidence-based interventions for chronic diseases.
Current operational status after ~2018 cannot be confirmed from available sources.
- Therapeutic areas
- OtherEndocrinologyCardiovascular
- Modalities
- Non-pharmacological therapy (Digital therapeutics)Device (if digital platform/app considered a device under FDA guidelines)
- Industry
- Digital Health Medical Devices
02
Partnerships
None publicly disclosed
Beyond the preview
Go deeper on FareWell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FareWell.